$CIEN

Rothenstein David M sold $1.1M of CIEN

Rothenstein David M (SVP and Chief Strategy Officer) sold 2,500 shares of CIENA CORP (CIEN) at $438.10 ($1.10M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Rothenstein David M
Published Aug 18, 2026, 9:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 9:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CIEN
Neutral
high confidence
Mentioned
$CIEN
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CIENNeutralLow
01

Why it matters

The newest fact is the specific sale size, price, and post-transaction holdings, but it does not include any new operational, financial, or regulatory development.

02

Market read

Insider selling can influence short-term sentiment, but 10b5-1 structure usually reduces interpretive value for fundamental trading.

03

What to watch

Because the plan is pre-arranged under Rule 10b5-1, the sale timing is not necessarily information-driven; position size and broader insider activity are not provided here.

Relevance 5/10Novelty 2/10Timing: filed 2026-08-18 after-hours; reflects sale executed 2026-08-14

Background

The article is an SEC Form 4 insider transaction disclosure for CIENA, reported by an officer under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$CIENNeutralHigh confidence
Context

CIENA disclosed an insider open-market sale by SVP and Chief Strategy Officer Rothenstein of 2,500 shares at $438.10 on 2026-08-14.

Expected impact

Likely minimal, unless traders overreact to insider selling despite the pre-arranged 10b5-1 structure.

Evidence & confidence

The filing specifies a pre-arranged Rule 10b5-1 plan and an open-market sale; Form 4 sales are typically not treated as new fundamental information.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Traders may treat the sale as a mild negative sentiment signal if they believe 10b5-1 plans can still coincide with management’s risk assessment.

Key entities

  • CIENA CORP

    Subject of the Form 4 insider transaction disclosure.

  • Rothenstein David M

    SVP and Chief Strategy Officer who sold shares via an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CIENMed

Ciena Stock Jumps Following Evercore ISI Upgrade to Outperform

Evercore ISI upgraded Ciena (CIEN) to Outperform, raising its price target to $550 from $375. The firm cited Ciena's role in optical networking for AI data centers, expecting 30%+ sales growth and 35%+ earnings growth annually. Ciena's Q3 revenue was $1.7B, up 37% YoY, with adjusted EPS of $2.11. The stock is up 164% in the last year.

$CIENMed

Evercore Just Upgraded Ciena Stock. Here's Why.

Evercore upgraded Ciena (CIEN) stock, citing long-term bullish outlook. Wall Street consensus remains 'Moderate Buy' with a mean price target of $514. Barchart shows 72% SELL opinion, suggesting short-term technical challenges.